Do psychedelics have therapeutic potential for obesity?

Classic psychedelics are being revisited as novel drug candidates. Researchers are investigating the efficacy of psychedelics for disorders such as depression and addiction. Facets of obesity pathophysiology are neurobiologically similar to these conditions, and we propose that obesity could be the next frontier in psychedelic research.

Automated summary

Classic psychedelics are being reconsidered as novel drug candidates for disorders like depression and addiction. The neurobiological similarities between facets of obesity pathophysiology and these conditions suggest that obesity could be the next frontier in psychedelic research.